178 related articles for article (PubMed ID: 22388763)
1. Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.
Prakash S; Hoffman R; Barouk S; Wang YL; Knowles DM; Orazi A
Mod Pathol; 2012 Jun; 25(6):815-27. PubMed ID: 22388763
[TBL] [Abstract][Full Text] [Related]
2. Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis.
Guy A; Bidet A; Ling C; Caumont C; Boureau L; Viallard JF; Parrens M
Virchows Arch; 2021 Oct; 479(4):755-764. PubMed ID: 33934231
[TBL] [Abstract][Full Text] [Related]
3. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
Pizzi M; Gergis U; Chaviano F; Orazi A
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
[TBL] [Abstract][Full Text] [Related]
4. Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders.
O'Malley DP; Kim YS; Perkins SL; Baldridge L; Juliar BE; Orazi A
Mod Pathol; 2005 Dec; 18(12):1550-61. PubMed ID: 16118626
[TBL] [Abstract][Full Text] [Related]
5. The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.
Hsieh PP; Olsen RJ; O'Malley DP; Konoplev SN; Hussong JW; Dunphy CH; Perkins SL; Cheng L; Lin P; Chang CC
Mod Pathol; 2007 Sep; 20(9):929-35. PubMed ID: 17643100
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.
Boiocchi L; Vener C; Savi F; Bonoldi E; Moro A; Fracchiolla NS; Iurlo A; Deliliers GL; Coggi G; Bosari S; Gianelli U
J Clin Pathol; 2011 Mar; 64(3):226-31. PubMed ID: 21217153
[TBL] [Abstract][Full Text] [Related]
7. Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study.
Wolf BC; Banks PM; Mann RB; Neiman RS
Am J Clin Pathol; 1988 Jan; 89(1):69-75. PubMed ID: 3276145
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
9. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
[TBL] [Abstract][Full Text] [Related]
10. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
Tovar-Bobadilla JL; Ortiz-Hidalgo C
Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
Mesa RA; Li CY; Schroeder G; Tefferi A
Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
Michiels JJ
Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142
[TBL] [Abstract][Full Text] [Related]
13. The spleen microenvironment influences disease transformation in a mouse model of KIT
Pelusi N; Kosanke M; Riedt T; Rösseler C; Seré K; Li J; Gütgemann I; Zenke M; Janzen V; Schorle H
Sci Rep; 2017 Jan; 7():41427. PubMed ID: 28128288
[TBL] [Abstract][Full Text] [Related]
14. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
15. Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia.
O'Malley DP; Orazi A; Wang M; Cheng L
Mod Pathol; 2005 Dec; 18(12):1562-8. PubMed ID: 16118625
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis.
Gebauer N; Bernard V; Gebauer W; Feller AC; Merz H
Acta Haematol; 2013; 129(4):251-6. PubMed ID: 23343777
[TBL] [Abstract][Full Text] [Related]
17. Tumor-like splenic extramedullary hematopoiesis in a patient with myelofibrosis.
Yokoyama T; Saigo K; Maeda N; Hamada Y; Yano Y; Mori T; Tamura M; Tasaka K; Okutani T; Takata M; Maeda Y; Tomofuji Y; Chinzei T
Intern Med; 2000 May; 39(5):416-8. PubMed ID: 10830186
[TBL] [Abstract][Full Text] [Related]
18. Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Zeeh FC; Meyer SC
Hamostaseologie; 2021 Jun; 41(3):197-205. PubMed ID: 34192778
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
20. Immunohistopathological Analysis of Extramedullary Hematopoiesis and Angiogenesis of Spleen in a Case of Primary Myelofibrosis with Huge Splenomegaly.
Kawano N; Saito N; Yoshida S; Kitanaka A; Shide K; Marutsuka K; Ohshima K; Shimoda K
Tohoku J Exp Med; 2022 Feb; 256(2):119-125. PubMed ID: 35173090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
